Disruptive Partnership: Charting the Future of Pan-Canadian Data & Analytics
Dr. Kim McGrail, HDRN Canada’s Scientific Director will participate in Symposium 2024 hosted by Canada’s Drug Agency as part of a panel titled Disruptive Partnership: Charting the Future of Pan-Canadian Data & Analytics. Symposium 2024 is a three-day hybrid event that gathers leaders from across Canada with expertise in policy, industry, health technology assessment, patient advocacy, medicine, public health, and communications. This year’s theme is From Disruption to Opportunity: Embracing Change in Health Care.